After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CMRX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Chimerix Inc is $393.94M. A total of 1.22 million shares were traded on the day, compared to an average of 4.69M shares.
In the most recent transaction, Melemed Allen S. sold 3,065 shares of CMRX for 4.50 per share on Feb 13 ’25. After the transaction, the CHIEF MEDICAL OFFICER now owns 152,875 company shares. In a previous transaction on Feb 13 ’25, Andriole Michael T. sold 7,370 shares at 4.52 per share. CMRX shares that PRESIDENT AND CEO owns now total 609,603.
Among the insiders who sold shares, Alrutz Michael Albert disposed of 1,600 shares on Feb 13 ’25 at a per-share price of $4.52. This resulted in the SVP AND GENERAL COUNSEL holding 213,596 shares of CMRX after the transaction. In another insider transaction, Jakeman David sold 300 shares at $4.53 per share on Feb 13 ’25. Company shares held by the VP OF FINANCE AND ACCOUNTING now total 148,987.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CMRX has a high of $4.58 and a low of $0.75.
As of this writing, CMRX has an earnings estimate of -$0.28 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.24 per share and a lower estimate of -$0.31.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CMRX’s latest balance sheet shows that the firm has $88.37M in Cash & Short Term Investments as of fiscal 2021. There were $16.39M in debt and $29.90M in liabilities at the time. Its Book Value Per Share was $1.51, while its Total Shareholder’s Equity was $68.25M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CMRX is Buy with a score of 5.00.
